These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 33527780)

  • 1. Mesenchymal stromal cell delivery via an ex vivo bioreactor preclinical test system attenuates clot formation for intravascular application.
    O'Rourke B; Nguyen S; Tilles AW; Bynum JA; Cap AP; Parekkadan B; Barcia RN
    Stem Cells Transl Med; 2021 Jun; 10(6):883-894. PubMed ID: 33527780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal Stromal Cell Bioreactor for Ex Vivo Reprogramming of Human Immune Cells.
    Allen A; Vaninov N; Li M; Nguyen S; Singh M; Igo P; Tilles AW; O'Rourke B; Miller BLK; Parekkadan B; Barcia RN
    Sci Rep; 2020 Jun; 10(1):10142. PubMed ID: 32576889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone Marrow-Derived Mesenchymal Stem Cells Have Innate Procoagulant Activity and Cause Microvascular Obstruction Following Intracoronary Delivery: Amelioration by Antithrombin Therapy.
    Gleeson BM; Martin K; Ali MT; Kumar AH; Pillai MG; Kumar SP; O'Sullivan JF; Whelan D; Stocca A; Khider W; Barry FP; O'Brien T; Caplice NM
    Stem Cells; 2015 Sep; 33(9):2726-37. PubMed ID: 25969127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 17β-estradiol improves the efficacy of exploited autologous bone marrow-derived mesenchymal stem cells in non-union radial defect healing: A rabbit model.
    Zamani Mazdeh D; Mirshokraei P; Emami M; Mirshahi A; Karimi I
    Res Vet Sci; 2018 Jun; 118():11-18. PubMed ID: 29334646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Mesenchymal Stromal Cells Isolated from Murine Adipose Tissue and Bone Marrow in the Treatment of Spinal Cord Injury.
    Takahashi A; Nakajima H; Uchida K; Takeura N; Honjoh K; Watanabe S; Kitade M; Kokubo Y; Johnson WEB; Matsumine A
    Cell Transplant; 2018 Jul; 27(7):1126-1139. PubMed ID: 29947256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioreactor for mobilization of mesenchymal stem/stromal cells into scaffolds under mechanical stimulation: Preliminary results.
    Gamez C; Schneider-Wald B; Schuette A; Mack M; Hauk L; Khan AUM; Gretz N; Stoffel M; Bieback K; Schwarz ML
    PLoS One; 2020; 15(1):e0227553. PubMed ID: 31923210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential.
    Gorman E; Millar J; McAuley D; O'Kane C
    Expert Rev Respir Med; 2021 Mar; 15(3):301-324. PubMed ID: 33172313
    [No Abstract]   [Full Text] [Related]  

  • 8. Sub-confluent culture of human mesenchymal stromal cells on biodegradable polycaprolactone microcarriers enhances bone healing of rat calvarial defect.
    Lam AT; Sim EJ; Shekaran A; Li J; Teo KL; Goggi JL; Reuveny S; Birch WR; Oh SK
    Cytotherapy; 2019 Jun; 21(6):631-642. PubMed ID: 30975604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different Procoagulant Activity of Therapeutic Mesenchymal Stromal Cells Derived from Bone Marrow and Placental Decidua.
    Moll G; Ignatowicz L; Catar R; Luecht C; Sadeghi B; Hamad O; Jungebluth P; Dragun D; Schmidtchen A; Ringdén O
    Stem Cells Dev; 2015 Oct; 24(19):2269-79. PubMed ID: 26192403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concise review: optimizing expansion of bone marrow mesenchymal stem/stromal cells for clinical applications.
    Hoch AI; Leach JK
    Stem Cells Transl Med; 2014 May; 3(5):643-52. PubMed ID: 24682286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of tissue factor expression and administration routes on thrombosis development induced by mesenchymal stem/stromal cell infusions: re-evaluating the dogma.
    Hoang VT; Le DS; Hoang DM; Phan TTK; Ngo LAT; Nguyen TK; Bui VA; Nguyen Thanh L
    Stem Cell Res Ther; 2024 Feb; 15(1):56. PubMed ID: 38414067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of MSCs and MSC-Derived Extracellular Vesicles on Human Blood Coagulation.
    Silachev DN; Goryunov KV; Shpilyuk MA; Beznoschenko OS; Morozova NY; Kraevaya EE; Popkov VA; Pevzner IB; Zorova LD; Evtushenko EA; Starodubtseva NL; Kononikhin AS; Bugrova AE; Evtushenko EG; Plotnikov EY; Zorov DB; Sukhikh GT
    Cells; 2019 Mar; 8(3):. PubMed ID: 30893822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving vasculoprotective effects of MSCs in coronary microvessels - benefits of 3D culture, sub-populations and heparin.
    Bumroongthai K; Kavanagh DPJ; Genever P; Kalia N
    Front Immunol; 2023; 14():1257497. PubMed ID: 37954606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compression Bioreactor-Based Mechanical Loading Induces Mobilization of Human Bone Marrow-Derived Mesenchymal Stromal Cells into Collagen Scaffolds In Vitro.
    Gamez C; Schneider-Wald B; Bieback K; Schuette A; Büttner S; Hafner M; Gretz N; Schwarz ML
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33158020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical-scale expansion of a mixed population of bone-marrow-derived stem and progenitor cells for potential use in bone-tissue regeneration.
    Dennis JE; Esterly K; Awadallah A; Parrish CR; Poynter GM; Goltry KL
    Stem Cells; 2007 Oct; 25(10):2575-82. PubMed ID: 17585167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravascular Stem Cell Bioreactor for Prevention of Adverse Remodeling After Myocardial Infarction.
    Johnston PV; Hwang CW; Bogdan V; Mills KJ; Eggan ER; Leszczynska A; Wu KC; Herzka DA; Brinker JA; Schulman SP; Banerjee M; Florea V; Natsumeda M; Tompkins B; Balkan W; Hare JM; Tomaselli GF; Weiss RG; Gerstenblith G
    J Am Heart Assoc; 2019 Aug; 8(15):e012351. PubMed ID: 31340693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pooled human serum: A new culture supplement for bioreactor-based cell therapies. Preliminary results.
    Savelli S; Trombi L; D'Alessandro D; Moscato S; Pacini S; Giannotti S; Lapi S; Scatena F; Petrini M
    Cytotherapy; 2018 Apr; 20(4):556-563. PubMed ID: 29429942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and cost-benefit analysis of automated bioreactor-expanded mesenchymal stem cells for clinical applications.
    Russell AL; Lefavor RC; Zubair AC
    Transfusion; 2018 Oct; 58(10):2374-2382. PubMed ID: 30203447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suspension-Expansion of Bone Marrow Results in Small Mesenchymal Stem Cells Exhibiting Increased Transpulmonary Passage Following Intravenous Administration.
    Zanetti A; Grata M; Etling EB; Panday R; Villanueva FS; Toma C
    Tissue Eng Part C Methods; 2015 Jul; 21(7):683-92. PubMed ID: 25567723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stromal cell secretomes are modulated by suspension time, delivery vehicle, passage through catheter, and exposure to adjuvants.
    Parsha K; Mir O; Satani N; Yang B; Guerrero W; Mei Z; Cai C; Chen PR; Gee A; Hanley PJ; Aronowski J; Savitz SI
    Cytotherapy; 2017 Jan; 19(1):36-46. PubMed ID: 27856228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.